Global Liver Cancer Diagnostics Market Expected to Reach Nearly US$ 700 Mn by 2022-end

The global market discussion on liver cancer diagnostics industry can be found in the latest study by Fact.MR, which has been freshly added to its massive collection of research database. The report is titled “Liver Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022”, which works to enlighten the readers about the major factors prompting the growth of the concerned market. Apart from that, the research majorly focuses on liver cancer diagnostics market’s competitive outlook by profiling major players functioning across the globe. As the report moves ahead, information regarding the prominent trends as well as opportunities in the key geographical segments have also been elaborated, thus enabling companies to be able to make region-specific strategies for gaining competitive lead. Some of the prime regions emphasized in the study include key regions.

Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=73

In its recent study, Fact.MR projects the global market for liver cancer diagnostics to exhibit a steady rise at 5.5% CAGR throughout the forecast period 2017 to 2022.

The fifth most prevalent cancer, liver cancer, caused 9.1% deaths among the overall population affected with cancer across the globe in 2012. Extreme aggressiveness and poor survival rate related to liver cancer has pushed this disease in becoming a crucial health issue worldwide. A slew of risk factors are associated with liver cancer including infection pertaining to hepatitis C virus (HCV), diabetes, obesity, diabetes, obesity, exposure to dietary aflatoxin, alcohol-induced cirrhosis, hepatitis B virus (HBV). With the capability of modification of these risk factors, strong prospects have been offered to lower its prevalence and mortality, by utilizing preventive strategies such as lifestyle modification, and hepatitis immunization. These factors are expected to fuel demand for liver cancer diagnostics across the globe.

Hepatocellular carcinoma (HCC), or, liver cancer is predicted to cause numerous deaths annually. With an aim of preventing liver cancer in reaching its final stage, the scientists across the world are developing a number of improved treatments as well as vaccines. Newer techniques developed for therapeutics of liver cancer render both liver transplant as well as partial hepatectomy more effective and safer. Leading medical research institutes worldwide are concentrating on development of advanced tests for complete diagnosis of liver cancer. The aforementioned factors are further estimated to drive growth of the global market for liver cancer diagnostics over the forecast period.

North America to Remain Dominant in the Global Liver Cancer Diagnostics Market

North America is expected to remain dominant in the global liver cancer diagnostics market, in terms of revenues. In addition, the markets for liver cancer diagnostics in North America and Europe are estimated to exhibit a parallel expansion at 5.6% CAGR through 2022. In contrast, markets in Japan and MEA are expected to exhibit a sluggish expansion during the forecast period.

Based on test type, biopsy test segment is expected to register the highest CAGR in the market through 2022, followed by LFTs. AFP test is estimated to remain preferred for liver cancer diagnostics in the global market. Revenue from AFP test is expected to account for over half share of the market in 2017, and is estimated to gain 52 BPS in its market share between 2017 and 2022.

Hospital-associated Labs to Remain Sought-after for Liver Cancer Diagnostics

Hospital-associated labs will continue to be sought-after for liver cancer diagnostics across the globe. Liver cancer diagnostics in hospital-associated labs will account for the largest revenues by 2022-end. Independent diagnostic laboratories will remain the second most lucrative end-users in the global liver cancer diagnostics market. In addition, liver cancer diagnostics in cancer research institutes are expected to register the fastest expansion over the forecast period.

Competition Tracking

The report has also profiled leading players in the global liver cancer diagnostics market, which include Illumina, Inc., Foundation Medicine, Inc., Danaher Corporation
Sysmex Corporation, and Biocept, Inc.

Browse Full Report with TOC- https://www.factmr.com/report/73/liver-cancer-diagnostics-market

Table of Content:

1. Global Liver Cancer Diagnostics Market – Executive Summary

2. Global Liver Cancer Diagnostics Market Overview
2.1. Introduction
2.1.1. Global Liver Cancer Diagnostics Market Taxonomy
2.1.2. Global Liver Cancer Diagnostics Market Definition
2.2. Global Liver Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Liver Cancer Diagnostics Market Y-o-Y Growth
2.3. Global Liver Cancer Diagnostics Market Dynamics
2.3.1. Drivers
2.3.2. Restraints
2.3.3. Trends
2.4. Supply Chain
2.5. Epidemiology
2.6. List of Distributors
2.7. Average Pricing Analysis
2.8. Regulations
2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Liver Cancer Diagnostics Market Analysis and Forecast By Test Type
3.1. Global Liver Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022
3.1.1. AFP Tests Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. LFTs Liver Cancer Diagnostics Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region

Continued….

Check Discount on This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=73

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/

This release was published on openPR.